Mortality News and Research

RSS

UH pharmacologist to explore cause and treatment for left ventricular non-compaction cardiomyopathy

University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for left ventricular non-compaction cardiomyopathy (LVNC).

5 Mar 2021

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

An innovative cell-based treatment for cancer has been found promising for the control of infections caused by fungi.

4 Mar 2021

Administering zinc supplements to Covid-19 patients may help reduce mortality and recovery time

Administering zinc supplements to Covid-19 patients with low levels of this element may be a strategy to reduce mortality and recovery time.

4 Mar 2021

Reduced ambulatory function in cancer survivors associated with increased risk of death

Bottom Line: Cancer survivors had a greater risk of reduced ambulatory function, which was associated with an increased risk of death.

4 Mar 2021

Researchers show potential benefits of delaying second mRNA COVID-19 vaccine dose

The currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the SARS-CoV-2 spike protein. Both companies designed their vaccines to be delivered in two doses. However, given the limited supply of vaccines worldwide, a new modeling study has suggested that vaccinating more people with the first dose and delaying the second could be an alternate route to achieving population immunity that could reduce mortality rates.

4 Mar 2021

Cell surface marker CD47 may allow early diagnosis of severe COVID-19

A new study reports the potential of the cell surface marker, CD47, as a biomarker for hyperinflammation, a characteristic feature of severe COVID-19.

4 Mar 2021

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

A new paper released on the medRxiv* preprint server describes, for the first time, the detection of antibodies to the virus in human breast milk following the vaccination of lactating mothers. This could guide patients, their healthcare providers, and public health policymakers alike as to the deployment of the vaccines in pregnant and lactating mothers.

4 Mar 2021

Improving nurse staffing in New York hospitals could reduce deaths, save money

According to a new study published in Medical Care, improving hospital nurse staffing as proposed in pending legislation in New York state would likely save lives.

3 Mar 2021

Repeated attendance at mammography screening confers protection against breast cancer mortality

Attending the two most recent screening appointments before a breast cancer diagnosis protects against breast cancer death, according to a Queen Mary study of over half a million Swedish women conducted over 24 years.

3 Mar 2021

Higher life satisfaction associated with positive health and well-being outcomes

New research from UBC finds that higher life satisfaction is associated with better physical, psychological and behavioral health.

3 Mar 2021

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

A team of UK scientists has recently evaluated the effectiveness of the Pfizer (BNT162b2) and AstraZeneca (ChAdOx1) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The findings reveal that both vaccines are effective in significantly reducing SARS-CoV-2 infection in older adults and providing long-term protection.

3 Mar 2021

Obesity may reduce COVID-19 vaccine efficacy, say researchers

A startling indicates that obesity may reduce the immune response to the current COVID-19 vaccines, along with other factors like age and sex. This could have significant implications for vaccination strategies in obese people.

3 Mar 2021

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

An interesting new preprint shows that even if countries are forced to delay the second dose of the current vaccines administered against SARS-CoV-2, to arrest the ongoing COVID-19 pandemic, the cumulative mortality would still fall significantly.

3 Mar 2021

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

Researchers at Imperial College London in the UK have reported on round five of the REal-time Assessment of Community Transmission-2 (REACT-2) program – a cross-sectional community survey measuring the prevalence of antibodies against the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among adults in England.

2 Mar 2021

Mortality News and Research

UH pharmacologist to explore cause and treatment for left ventricular non-compaction cardiomyopathy

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Administering zinc supplements to Covid-19 patients may help reduce mortality and recovery time

Reduced ambulatory function in cancer survivors associated with increased risk of death

Researchers show potential benefits of delaying second mRNA COVID-19 vaccine dose

Cell surface marker CD47 may allow early diagnosis of severe COVID-19

Researchers detect vaccine-induced SARS-CoV-2 antibodies in breast milk

Improving nurse staffing in New York hospitals could reduce deaths, save money

Repeated attendance at mammography screening confers protection against breast cancer mortality

Higher life satisfaction associated with positive health and well-being outcomes

UK public health authorities review early data on the effectiveness of Pfizer and AstraZeneca COVID-19 vaccines

Obesity may reduce COVID-19 vaccine efficacy, say researchers

Delayed second dose strategy with mRNA vaccines may reduce COVID-19 mortality, say researchers

Survey reveals impact of Pfizer-BioNTech vaccination in the UK

A simple blood draw may help discover tumor reactive immune cells to treat advanced melanoma

FAIR Health study highlights the impact of COVID-19 on pediatric mental health

SARS-CoV-2 UK variant shows low virulence and high shedding in hamster model

Sorting out how politics, policies figure in flap over New York nursing home Covid death rates

Successful SARS-CoV-2 vaccination hinges on non-pharmaceutical interventions and vaccine deployment strategies

Moderna vaccine reduces viral spread by at least 60 percent, finds study

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News